Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 86
Filtrar
1.
Med Parazitol (Mosk) ; (1): 42-6, 2016.
Artículo en Ruso | MEDLINE | ID: mdl-27029145

RESUMEN

OBJECTIVE: to assess the present state of the natural tularemia foci of different landscape epidemiological types, by using individual focal areas as an example. MATERIALS AND METHODS: Epizootological monitoring and epidemiological analysis were conducted in the areas of natural tularemia foci of tundra (Wrangel Island), meadow-field (Central Federal District of the Russian Federation), flood-swamp (Arkhangelsk Region, Khanty-Mansi Autonomous District), and steppe (Mongolii) types. Small mammals (organs, blood), tularemia patients' sera, and environniental objects were examined. Molecular genetic and immune serological diagnostic assays were used. The incidence of tularemia in the past decade was analyzed using the maps for the epidemiological examinations of tularemia cases and medical reports. RESULTS: The natural foci of tularemia were established to continue to actively operate. There were 2913 cases of tularemia in the Russian Federation in 2001 to 2014. The flood-swamp natural foci, in which there were summer transmissive tularemia outbreaks, the largest of high occurred in Khanti-Mansiysk in 2013 when a total of 1005 people fell ill, are a special epidemic hazard. Analysis of the tularemia outbreaks suggests that there is a need for continuous epizootological monitoring of the areas of natural tularemia foci for the timely prediction and prevention of epidemic complications. It is noted that there is an unfounded reduction in the scope of preventive measures, and immunoprevention in particular, and a weaker control of the antitularemia immune status in the population residing in the area of active natural foci of tularemia.


Asunto(s)
Vacunas Bacterianas/provisión & distribución , Brotes de Enfermedades , Reservorios de Enfermedades/veterinaria , Mamíferos/microbiología , Tularemia/epidemiología , Tularemia/prevención & control , Zoonosis/epidemiología , Animales , Vacunas Bacterianas/administración & dosificación , Vacunas Bacterianas/inmunología , Reservorios de Enfermedades/microbiología , Monitoreo Epidemiológico , Heces/microbiología , Femenino , Francisella tularensis/inmunología , Francisella tularensis/aislamiento & purificación , Pradera , Humanos , Programas de Inmunización/organización & administración , Islas , Masculino , Federación de Rusia/epidemiología , Tularemia/inmunología , Tularemia/microbiología , Vacunación/estadística & datos numéricos , Humedales , Zoonosis/microbiología
2.
Artículo en Ruso | MEDLINE | ID: mdl-26259271

RESUMEN

AIM: Enhancement of tularemia laboratory diagnostics by F. tularensis DNA determination in blood sera of patients using real time polymerase chain reaction (RT-PCR). MATERIALS AND METHODS: 39 blood sera of patients obtained during transmissive epidemic outbreak of tularemia in Khanty-Mansiysk in 2013 were studied in agglutination reaction, passive hemagglutination, RT-PCR. Specific primers and fluorescent probes were used: ISFTu2F/R+ISFTu2P, Tu14GF/R+tul4-PR2. RESULTS: Advantages of using RT-PCR for early diagnostics of tularemia, when specific antibodies are not detected using traditional immunologic methods, were established. Use of a combination of primers and ISFTu2F/R+ISFTu2P probe allowed to detect F. tularensis DNA in 100% of sera, whereas Tul4G F/R+tul4-PR2 combination--92% of sera. The data were obtained when DNA was isolated from sera using "Proba Rapid" express method. Clinical-epidemiologic diagnosis oftularemia was confirmed by both immune-serologic and RT-PCR methods when sera were studied 3-4 weeks after the onset of the disease. CONCLUSION: RT-PCR with ISFTu2F/R primers and fluorescent probe ISFTu2P, having high sensitivity and specificity, allows to determine F. tularensis DNA in blood sera of patients at both the early stage and 3-4 weeks after the onset of the disease.


Asunto(s)
Francisella tularensis/aislamiento & purificación , Reacción en Cadena en Tiempo Real de la Polimerasa , Tularemia/sangre , Brotes de Enfermedades , Francisella tularensis/genética , Francisella tularensis/patogenicidad , Humanos , Laboratorios , Tularemia/microbiología , Tularemia/patología
3.
Artículo en Ruso | MEDLINE | ID: mdl-26016340

RESUMEN

AIM: Detection of contemporary features of tularemia focimanifestations, determination of territories of high epidemic risk in various landscape zones and creation of a map of foci territories of Moscow Region for isolation of tularemia infectious agent cultures and registered human morbidity for justified planning of prophylaxis measures. MATERIALS AND METHODS: Report materials of epizootologic examinations of natural foci for 1965-2013, 156 maps of epidemiologic examination of cases of human infection with tularemia, results of studies of casting of predatory birds and dung of predatory mammals were used. Registered morbidity and isolation of tularemia infectious agent cultures from 1965 to date were applied to an electronic map of Moscow Region by sign method using modern. GIS-technologies (MapInfo 10.5 program). Electronic maps Ingit at 1:200,000 scale, as well as Google Earth program were used to search for base points. RESULTS: Analysis of morbidity has revealed structure change in human tularemia morbidity--an increase of the fraction of urban population and a decrease of the fraction of patients among rural inhabitants, unimmunized against this infection are mostly ill. The presence of DNA of tularemia causative agent in biological objects in the complex with serologic and bacteriological studies was shown to allow to detect flaccid epizootics even at low numbers of rodents. CONCLUSION: Cartographic reflection of registered morbidity and isolation of tularemia infectious agent cultures allowed to show territories with various degrees of epizootic activity and epidemic manifestation. Positive results of serologic and molecular-genetic studies of environmental objects gives evident on epizootic activity and constant risk of aggravation of epidemic situation for this infection.


Asunto(s)
Brotes de Enfermedades , Infección Focal , Francisella tularensis/aislamiento & purificación , Tularemia/epidemiología , Zoonosis/epidemiología , Animales , Aves/microbiología , Carnívoros/microbiología , Reservorios de Enfermedades/microbiología , Monitoreo Epidemiológico , Heces/microbiología , Francisella tularensis/patogenicidad , Sistemas de Información Geográfica , Humanos , Estudios Retrospectivos , Roedores/microbiología , Población Rural , Federación de Rusia/epidemiología , Análisis Espacio-Temporal , Tularemia/microbiología , Tularemia/fisiopatología , Tularemia/transmisión , Población Urbana , Zoonosis/microbiología , Zoonosis/transmisión
4.
Artículo en Ruso | MEDLINE | ID: mdl-25842947

RESUMEN

AIM: Improvement of monitoring and prognosis of epidemic manifestations of natural foci of tularemia on the territory of Voronezh region using immune-serological and molecular-genetic study of main carriers of the disease. MATERIALS AND METHODS: 539 small mammals captured during summer period of 2011 in 4 districts of North-Eastern part of Voronezh region were studied. Animal organs were studied by serologic (search for Francisella tularensis antigens) and molecular-biologic (detection of F. tularensis DNA) methods. Tularemia antigen was detected using passive hemagglutination reaction (PHAR) with erythrocytic tularemia immunoglobulin diagnosticum. Real-time polymerase chain reaction (RT-PCR) was applied for detection of tularemia causative agent DNA. RESULTS: Complex study revealed epizootic activity of natural foci of tularemia in the examined territory. F. tularensis antigen and/or DNA were detected in 82 objects (15.2%). Use of RT-PCR allowed to additionally detect samples with relatively low content of F. tularensis DNA substrate, when antigen was not detected in samples. High sensitivity and specificity of the RT-PCR was ensured by inclusion of specific probes (tu14-PR2 and ISFTu2P). CONCLUSION: The results obtained give evidence on functioning and epizootic activity of natural foci of tularemia in Voronezh region that requires constant monitoring of the territory and prophylaxis measures, first of all vaccination of risk groups by live tularemia vaccine.


Asunto(s)
ADN Bacteriano/aislamiento & purificación , Francisella tularensis/genética , Tularemia/epidemiología , Tularemia/transmisión , Animales , Francisella tularensis/aislamiento & purificación , Francisella tularensis/patogenicidad , Hemaglutininas/genética , Humanos , Mamíferos/microbiología , Federación de Rusia , Tularemia/microbiología
5.
Mol Gen Mikrobiol Virusol ; (3): 22-5, 2013.
Artículo en Ruso | MEDLINE | ID: mdl-24364141

RESUMEN

Typing of Francisella strains collection by means of PCR on the basis of tul4 and RDI genes was carried out. The identification of the species and subspecies of the 112 strains of Francisella tularensis was reashed. The PCR on DNA-targets loci of type IV pili genes: pilA, pilE2, pilE3, pilE4, pilE5, pilF, pilT, pilD and pilQ for differentiation of F. tularensis strains on virulence was carried out. It was demonstrated the possibility of differentiation of F. tularensis strains in PCR (primers A-B) on the basis of the revelation of the gene pilA in virulent strains of third subspecies F. tularensis and F. tularensis subsp. novicida. This gene pilA was not detected in the vaccine strain 15/10 and its variants, as well as in the most of avirulent F. tularensis subsp. holarctica strains. However, the fragment gene pilA was found in the attenuated strains F. tularensis subsp. tularensis and mediasiatica. It was not revealed any differences on other targets of pili genes between of F. tularensis strains, with the exception of the strain F. tularensis subsp. novicida Utah 112, which had not a fragment of the gene pilE2. The use of PCR to target the locus of the pilA gene allows to discriminate virulent F. tularensis subsp. holarctica strains from the vaccine 15/10, its variants and avirulent strains.


Asunto(s)
Vacunas Bacterianas/genética , Francisella tularensis , Genes Bacterianos , Sitios Genéticos , Factores de Virulencia/genética , Francisella tularensis/clasificación , Francisella tularensis/genética , Francisella tularensis/patogenicidad
6.
Prikl Biokhim Mikrobiol ; 49(6): 554-60, 2013.
Artículo en Ruso | MEDLINE | ID: mdl-25434179

RESUMEN

The physicochemical and enzymatic properties of hybrid analogues of the Brevundimonas diminuta Gl7ACA-acylase (BrdGIA), containing the N-terminal chitin-binding domain of the bacterial chitinase (BrdG1A/NmChBD) or the C-terminal oligohistidine sequence (BrdGIA/H), were studied. An enhanced thermostability level of BrdG1A/NmChBD could suggest the stabilizing effect of the chitin-binding domain. An analysis of pH profiles of the enzymatic activity of recombinat BrdGIA analogues did not reveal significant differences: the catalytic activity of both variants changed slightly in the.interval ofpH values from 6.0 to 9.0 but drastically decreased at lower pH values. Both analogues demonstrated similar sensitivity towards denaturing agents: addition of 2.0 M ofguanidine chloride resulted in the complete inactivation of both enzymes. A scheme was developed for obtaining isolated recombinant alpha- and beta-subunits of BrdGLA. In vitro enzyme reconstructions indicated that the alpha-subunit was necessary for the formation of a correct spatial structure of the beta-subunit and for the formation of a functionally active enzyme.


Asunto(s)
Amidohidrolasas/química , Proteínas Bacterianas/química , Caulobacteraceae/enzimología , Amidohidrolasas/genética , Proteínas Bacterianas/genética , Caulobacteraceae/genética , Estabilidad de Enzimas , Estructura Cuaternaria de Proteína , Estructura Terciaria de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/genética
7.
Med Parazitol (Mosk) ; (3): 40-4, 2013.
Artículo en Ruso | MEDLINE | ID: mdl-25924284

RESUMEN

Long-term annual monitoring of the natural foci of tularemia was first made on Wrangel Island. The objects of the investigation were pellets of birds-myophages, blood samples from rodents, and excrements from carnivorous mammals. A total of 2626 biological samples were examined in the period 2002 to 2011. A serological test was ascertained to be the most effective method for the detection of tularemia epizooties; polymerase chain reaction should be used as an additional technique to examine blood samples, as well as rodent tubular bone debris taken from the pellets. Tularemia epizooties were registered in the populations of two species of lemmings every year, except in 2003. An intensive diffuse tularemia epizooty was first detected in this area, which emerged in 2019, peaked by spring 2011, and covered most of the island. The antigen of tularemia pathogen was identified in 43.46% of the samples under examination,which is a high quantitative indicator of the intensity of an epizootic process. The fact that positive samples are annually found in the same areas of the island suggests that the causative agent is steadily and long preserved in the parasitic system. The availability of stable and active natural tularemia foci on Wrangel Island calls for preventive measures, particularly vaccination of risk groups coming to the island to conduct researches.


Asunto(s)
Anticuerpos Antibacterianos/sangre , ADN Bacteriano/genética , Infección Focal , Francisella tularensis/aislamiento & purificación , Tularemia/epidemiología , Tularemia/veterinaria , Animales , Regiones Árticas/epidemiología , Arvicolinae/microbiología , Heces/microbiología , Zorros/microbiología , Francisella tularensis/genética , Francisella tularensis/inmunología , Islas , Federación de Rusia/epidemiología , Estrigiformes/microbiología , Tularemia/microbiología
8.
Artículo en Ruso | MEDLINE | ID: mdl-22145346

RESUMEN

AIM: Study of the current spread of natural tularemia foci in Mongolia and its epizootic activity evaluation for consequent substantiation of the recommendations for prophylaxis of this disease. MATERIALS AND METHODS: Study of 1119 pellet specimens from predatory birds obtained in 6 aimag in Mongolia in 2008--2010 was performed. Tularemia antigen was detected by using antibody neutralization reaction (ANR) and passive hemagglutination reaction (PHR) with tularemia diagnosticums. Tularemia DNA was detected by PCR by using strain specific primers. Presence of plague antigen in PHR with plague immunoglobulin diagnosticum was also studied in all the samples. RESULTS: Epizootologic monitoring allowed the detection of natural tularemia foci in 5 of the 6 studied aimags in Mongolia. PHR was the most effective study method that allowed to detect tularemia antigen in the environmental objects in high quantities (up to 9.2% of positive samples) and high titers (up to 1:1600). PCR was less effective. Plague antigen was detected in 9 samples in 2010 for the first time, and in 3 cases together with tularemia antigen, which indicates a presence of combined natural foci of tularemia and plague in this territory. CONCLUSION: In the studied regions of Mongolia natural tularemia foci were detected, their epizootic activity was determined and recommendations for future study tactics of natural tularemia foci were given.


Asunto(s)
Francisella tularensis/aislamiento & purificación , Tularemia/epidemiología , Animales , Anticuerpos , Aves/microbiología , Reservorios de Enfermedades/microbiología , Humanos , Mongolia/epidemiología , Roedores/microbiología , Tularemia/microbiología
9.
Aliment Pharmacol Ther ; 34(9): 1088-97, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21929562

RESUMEN

BACKGROUND: Ulcerative colitis (UC) is characterised by impaired fatty-acid oxidation; l-carnitine has a key role in fatty-acid metabolism and short-chain fatty acids such as butyrate and propionate are important energy source for intestinal epithelial cells. AIM: To evaluate efficacy and safety of colon-release propionyl-L-carnitine (PLC) in patients with mild-to-moderate UC receiving stable oral aminosalicylate or thiopurine therapy. METHODS: In a multicentre, phase II, double-blind, parallel-group trial, patients were randomised to receive PLC 1 g/day, PLC 2 g/day or placebo. Main inclusion criteria were as follows: age 18-75; disease activity index (DAI) score 3-10 inclusive, be under oral stable treatment with aminosalicylate or thiopurine. The primary endpoint was clinical/endoscopic response, defined as a decrease in DAI score ≥ 3 points or remission, defined as a DAI score ≤ 2 with no individual sub-score > 1. RESULTS: Of 121 patients who were randomised, 57 of 79 (72%) patients receiving PLC (combined 1 g and 2 g cohort) had a clinical/endoscopic response vs. 20 of 40 (50%) receiving placebo (P = 0.02). Specifically, in PLC 1 g/day group, 30 of 40 (75%) patients had clinical/endoscopic response (P = 0.02 vs. placebo) and 27 of 39 (69%) in the PLC 2 g/day group (P = 0.08 vs. placebo). Rates of remission were 22/40 (55%), 19/39 (49%), 14/40 (35%) in the PLC 1 g, PLC 2 g, and placebo groups, respectively. PLC had a similar safety profile to placebo; the most common adverse events were gastrointestinal. CONCLUSION: Propionyl-L-carnitine 1 g/day should be investigated further as a co-treatment for mild-to-moderate ulcerative colitis (NCT-01026857).


Asunto(s)
Antiinflamatorios no Esteroideos/administración & dosificación , Carnitina/análogos & derivados , Colitis Ulcerosa/tratamiento farmacológico , Administración Oral , Adulto , Antiinflamatorios no Esteroideos/efectos adversos , Carnitina/administración & dosificación , Carnitina/efectos adversos , Estudios de Cohortes , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Adulto Joven
10.
Aliment Pharmacol Ther ; 33(3): 313-22, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21138455

RESUMEN

BACKGROUND: Comparative data regarding different regimens of oral mesalazine (mesalamine) for maintaining remission in ulcerative colitis are limited. AIM: To evaluate whether 3.0 g mesalazine once-daily (OD) is superior to the standard treatment of 0.5 g mesalazine three times daily (t.d.s.) and to prove the therapeutic equivalence of OD vs. t.d.s. dosing of total 1.5 g mesalazine for remission maintenance in patients with ulcerative colitis. METHODS: A 1-year, multicentre, double-blind, double-dummy study was undertaken in patients with endoscopically and histologically confirmed ulcerative colitis in remission. Patients were randomised to oral mesalazine 3.0 g OD, 1.5 g OD or 0.5 g t.d.s. The primary efficacy endpoint was the proportion of patients still in clinical remission at the final visit, with clinical relapse being defined as CAI score >4 and an increase of ≥3 from baseline. RESULTS: The primary efficacy endpoint occurred in 162/217 3.0 g OD patients (75%), 129/212 1.5 g OD patients (61%) and 150/218 0.5 g t.d.s. patients (69%) in the intention-to-treat population, and in 152/177 (86%), 121/182 (67%) and 144/185 (78%) in the per protocol population respectively; 3.0 g OD was superior to both low-dose regimens for the primary endpoint (i.e. P < 0.001, 3.0 g OD vs. 1.5 g OD; P = 0.024, 3.0 g OD vs. 0.5 g t.d.s.; superiority test, per protocol population). Safety analysis, including comprehensive renal monitoring, revealed no concern in any treatment group. CONCLUSION: Mesalazine 3.0 g once daily was the most effective dose for maintenance of remission in ulcerative colitis of the three regimens assessed, with no penalty in terms of safety.


Asunto(s)
Antiinflamatorios no Esteroideos/administración & dosificación , Colitis Ulcerosa/tratamiento farmacológico , Mesalamina/administración & dosificación , Administración Oral , Adulto , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Inducción de Remisión , Estadística como Asunto , Factores de Tiempo , Resultado del Tratamiento
11.
Vestn Khir Im I I Grek ; 169(1): 53-7, 2010.
Artículo en Ruso | MEDLINE | ID: mdl-20387607

RESUMEN

The authors describe results of surgical treatment of 112 patients operated for a severe resistant form of ulcerative colitis (UC). In 26 (23.2%) of observations the operations were performed for complications, in 65 (58%)--for hormone-resistent, and in 21 (18.8%)--for hormone-dependent forms of UC. In 80 (71.4%) cases subtotal resection of the colon with ileo- and sigmostomies was fulfilled, in 26 (23.2%) a single stage ablation of all large intestine was fulfilled with the formation of permanent ileostomy and in 5 (5.4%) of observations the first step was finished with the formation of a reconstructive-plastic reservoir anastomosis. The number of complications in the nearest postoperative period was in 12.8% of patients, lethality was 2.3%. The development of a strict strategy of treatment for severe forms of the disease including the present-day using conservative and surgical methods of treatment depending on the individual character of each patient with UC made it possible to minimize the number of postoperative complications and decrease lethality and also to restore anal defecation with good functional results in 30.1% of operated patients.


Asunto(s)
Colectomía/métodos , Colectomía/estadística & datos numéricos , Colitis Ulcerosa/cirugía , Colon Sigmoide/cirugía , Reservorios Cólicos/estadística & datos numéricos , Toma de Decisiones , Ileostomía/métodos , Adolescente , Adulto , Anciano , Anastomosis Quirúrgica , Colitis Ulcerosa/fisiopatología , Defecación , Femenino , Humanos , Ileostomía/estadística & datos numéricos , Incidencia , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/epidemiología , Estudios Retrospectivos , Federación de Rusia/epidemiología , Tasa de Supervivencia/tendencias , Resultado del Tratamiento , Adulto Joven
12.
Am J Gastroenterol ; 103(9): 2284-92, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18671816

RESUMEN

OBJECTIVES: A prospective study was undertaken to compare the efficacy of everolimus versus azathioprine or placebo in maintaining steroid-induced remission in active Crohn's disease (CD) and assess the safety and pharmacokinetics of everolimus. METHODS: This was a randomized, double-blind, placebo-controlled, proof-of-concept study in adults with moderate-to-severe active CD. The patients received oral steroids for a rapid induction of remission plus everolimus 6 mg/day, azathioprine 2.5 mg/kg/day, or placebo as maintenance treatment. The main outcome measure was the treatment success, defined as a steroid-free remission by the end of month 3 and maintained until study cutoff without the use of prohibited efficacy treatments. RESULTS: Following an interim analysis, the study was terminated before enrollment was completed due to the lack of efficacy. The full intent-to-treat population comprised 138 patients. Only 96 patients who entered the study > or =7 months prior to data cutoff were included in the primary efficacy population. The treatment success was achieved in 13 of 38 everolimus patients, 22 of 36 azathioprine patients, and 8 of 22 placebo patients. Using the Kaplan-Meier estimates at month 7, the incidence of treatment success was 22.0% with everolimus group (95% confidence interval [CI] 6.7-37.3%, P= 0.610 vs placebo), 38.3% with azathioprine group (95% CI 20.6-55.9%, P= 0.500 vs placebo), and 28.8% with placebo group (95% CI 7.7-49.9%). The type and incidence of adverse events in the everolimus cohort were similar to those reported in the approved transplantation indications. CONCLUSIONS: The safety and tolerability of everolimus (6 mg/day) in patients with active CD were comparable to azathioprine. At this dose, everolimus is not more efficacious in achieving a steroid-free remission in active CD than the comparators.


Asunto(s)
Azatioprina/uso terapéutico , Enfermedad de Crohn/tratamiento farmacológico , Inmunosupresores/uso terapéutico , Sirolimus/análogos & derivados , Adolescente , Adulto , Anciano , Azatioprina/farmacocinética , Enfermedad de Crohn/fisiopatología , Método Doble Ciego , Everolimus , Femenino , Humanos , Inmunosupresores/farmacocinética , Masculino , Persona de Mediana Edad , Placebos , Estudios Prospectivos , Sirolimus/farmacocinética , Sirolimus/uso terapéutico , Estadísticas no Paramétricas , Esteroides/uso terapéutico , Resultado del Tratamiento
14.
Klin Med (Mosk) ; 85(1): 44-7, 2007.
Artículo en Ruso | MEDLINE | ID: mdl-17419355

RESUMEN

The authors analyzed the clinical picture in 18 patients with distal lesion of the colon and an inflammatory focus in the cecum (segmentary lesion), and five patients with distal lesion of the colon revealed with endoscopy and pathomorphological signs of inflammation in visually intact cecum. The analysis shows that in a range of cases the extent of lesion in ulcerous colitis (UC) cannot be determined correctly with colonoscopy. An apparent segmentary character of lesion (inflammation in the distal colon and an inflammatory focus in the cecum) is an additional criterion of unfavorable prognosis of transformation into disseminated UC forms. Such patients need application of the same treatment regimens as in patients with disseminated UC forms.


Asunto(s)
Ciego/patología , Colitis Ulcerosa/patología , Colon/patología , Adolescente , Adulto , Anciano , Biopsia , Colitis Ulcerosa/tratamiento farmacológico , Colonoscopía , Femenino , Estudios de Seguimiento , Glucocorticoides/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Prednisolona/uso terapéutico , Estudios Retrospectivos , Índice de Severidad de la Enfermedad
17.
Khirurgiia (Mosk) ; (5): 39-45, 2004.
Artículo en Ruso | MEDLINE | ID: mdl-15159758

RESUMEN

From 1990 to 2002 seventy-nine patients with hormone-resistant form of nonspecific ulcerative colitis (NUC) underwent surgery. There were 37 men, 42 women, mean age was 34.4 +/- 3.8 years. Severe form of NUC was in all the patients, total lesion of the colon was in 60.8% cases, subtotal - in 25.3%, and right-sided - in 13.9%. Acute disease was seen in 21 (26.6%) patients, chronic recurrent - in 42 (53.2%), chronic continuous - in 16 (20.2%). Complex intensive treatment including glucocorticoids (prednisolon 2 mg/kg/day) was used in all the patients. Criteria of efficacy were clinical, laboratory and instrumental data (rate of stool, hemodynamics, hyperthermia, pain syndrome, hemoglobin, level of leukocytes and albumin, results of endoscopy and roentgenoscopy). Absence of positive results during 3 weeks was regarded as inefficacy of therapy and indication for surgery. Subtotal resection of the colon with ileostoma or sygmostoma was performed in 68 patients. Detection of resistance to hormones before development of NUC's intestinal complications (intestinal bleeding, toxic dilatation and perforation of colon) permitted to improve results of surgery: number of postoperative complications reduced from 60 to 8 - 9%, lethality - from 21 to 4.6%.


Asunto(s)
Colitis Ulcerosa/cirugía , Adolescente , Adulto , Anciano , Colitis Ulcerosa/tratamiento farmacológico , Colitis Ulcerosa/mortalidad , Colostomía/efectos adversos , Resistencia a Medicamentos , Femenino , Glucocorticoides/uso terapéutico , Humanos , Ileostomía/efectos adversos , Masculino , Persona de Mediana Edad , Prednisolona/uso terapéutico , Factores de Tiempo , Resultado del Tratamiento
18.
Vestn Rentgenol Radiol ; (4): 33-40, 2004.
Artículo en Ruso | MEDLINE | ID: mdl-15626233

RESUMEN

The misdiagnosis rate in defining the cause of obstructive colonic disease is 8.2-24.4%. This is consistent with the fact that every 5 patients with colonic obstruction present difficulties in establishing the nature of a pathological process. The paper provides the results of analysis of clinical and X-ray symptoms in 350 patients with difficult differentially diagnosed cases of narrowing of the rectum and colon. Based on the analysis, the authors identified the basically important X-ray signs that might differentiate tumor stenoses from other obstructive diseases. They also defined the specific X-ray signs of such diseases as infiltrative cancer; extraintestinal cancer involved in the large bowel; inflammatory strictures in ulcerative colitis, diverticulosis, actinomycosis, tuberculosis, intestinal endometriosis, invagination, and other obstructive diseases. The developed differentiated diagnostic criteria could enhance the overall accuracy of X-ray study in this difficult group of patients from 72.7-80% to 93%.


Asunto(s)
Enfermedades del Colon/diagnóstico por imagen , Obstrucción Intestinal/diagnóstico por imagen , Enfermedades del Recto/diagnóstico por imagen , Neoplasias Colorrectales/diagnóstico por imagen , Constricción Patológica/diagnóstico por imagen , Diagnóstico Diferencial , Humanos , Radiografía , Sensibilidad y Especificidad
19.
Med Parazitol (Mosk) ; (3): 22-6, 2001.
Artículo en Ruso | MEDLINE | ID: mdl-11680366

RESUMEN

The specific features of hantavirus infection in naturally infected bank voles (Clethrionomys glareolus), the principal host of hantavirus of the serotype Puumala, were studied during long-term observation of individually marked animals in the active focus of hemorrhagic fever with renal syndrome (HFRS) in the south of Udmurtia. The infection time in the bank voles was defined by paired serum seroconversion tests. In the natural focus, hantavirus was shown to cause asymptomatic persistent infection in the bank voles with the body's peak accumulation of the virus and its environmental discharge within the first month of infection. In this period the animals present the greatest epidemic and epizootic hazards. Hantavirus infection has no negative impact on the viability of bank voles.


Asunto(s)
Enfermedades de los Animales/virología , Arvicolinae/virología , Reservorios de Enfermedades , Infecciones por Hantavirus/veterinaria , Enfermedades de los Animales/transmisión , Animales , Transmisión de Enfermedad Infecciosa , Infecciones por Hantavirus/transmisión , Infecciones por Hantavirus/virología , Pulmón/virología
20.
Arch Virol ; 144(12): 2415-28, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10664394

RESUMEN

Specific features of hantavirus infection in bank vole (Clethrionomys glareolus) were studied in the endemic area of hemorrhagic fever with renal syndrome (HFRS) in the foothills of the Ural mountains, using long-term observations on living animals by the capture-mark-recapture (CMR) method. The results demonstrated that the infection naturally circulating in the voles is chronic (lasting for up to 15 months) and asymptomatic, with a peak of Puumala virus accumulation and release from the organism during the first month after infection. It was shown that the bank vole population includes young animals with maternal immunity, which remain resistant to the Puumala virus infection for 3-3.5 months. The infection rate in voles depended on the age and sexual maturity of animals. The greatest proportion of seropositive animals was observed among overwintered males. Seroconversion in voles was more frequent during the period of high reproductive activity.


Asunto(s)
Arvicolinae/virología , Infecciones por Hantavirus/veterinaria , Orthohantavirus/fisiología , Enfermedades de los Roedores/virología , Envejecimiento , Animales , Anticuerpos Antivirales/sangre , Antígenos Virales/análisis , Arvicolinae/fisiología , Susceptibilidad a Enfermedades , Femenino , Orthohantavirus/inmunología , Orthohantavirus/aislamiento & purificación , Infecciones por Hantavirus/inmunología , Infecciones por Hantavirus/transmisión , Infecciones por Hantavirus/virología , Inmunidad Materno-Adquirida , Masculino , Reproducción , Enfermedades de los Roedores/inmunología , Enfermedades de los Roedores/transmisión , Estaciones del Año , Caracteres Sexuales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA